MINDSPACE Strategy for Risk Optimization

Summary

The purpose of this study is to find out which types of written stroke messages may help high risk stroke patients take action to improve their health.

Conditions

• Stroke

Interventions

BEHAVIORAL

Standard

Investigators will develop a "standard" informational stroke risk message that will not undergo iterative review. This will inform the patient that based on information in the healthcare system, the patient is at higher risk of stroke than many others receiving care in the patient's healthcare system; it will describe options for working with their health care team to reduce the risk of stroke; and encourage the patient to call the health navigator to discuss these options and make a decision about next steps to take to reduce the patient's risk of stroke.

BEHAVIORAL

Incentive

Investigators anticipate that the baseline incentive stroke risk message will inform the patient that they are at higher risk of stroke than many others receiving care in the patient's healthcare system, and will provide information about obtaining an incentive if the patient calls to make contact with a health navigator who will help them plan a next step to reduce their stroke risk. The investigators also anticipate including information that all patients who call will also be entered in a random drawing to receive an additional incentive, with up to six patients receiving this incentive.

BEHAVIORAL

Salience

Investigators anticipate that the baseline salience stroke risk message will inform the patient that they are at higher risk of stroke than many other patients receiving care in the patient's healthcare system, and will specifically focus on the patient's own risk factors (rather than all stroke risk factors). The salience message will also include visual depictions of stroke patients that are gender and ethnically matched to each subject. This is intended to prompt action by emphasizing that stroke is a real possibility for "patients like me."

BEHAVIORAL

Incentive + Salience

Combined message of incentive plus salience.

Sponsors & Collaborators

• Genentech, Inc.

  collaborator INDUSTRY

• Regenstrief Institute, Inc.

  collaborator OTHER

• Richard L. Roudebush VA Medical Center

  collaborator FED

• Indiana Institute for Medical Research

  lead OTHER

Principal Investigators

• Linda S Williams, MD · Richard L. Roudebush VA Medical Center

Study Design

Allocation

RANDOMIZED

Purpose

HEALTH_SERVICES_RESEARCH

Masking

NONE

Model

PARALLEL

Eligibility

Min Age

18 Years

Sex

ALL

Healthy Volunteers

No

Timeline & Regulatory

Start

2016-06-30

Primary Completion

2018-08-31

Completion

2018-08-31

Countries

• United States

Study Locations